Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge.
about
Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunityOral Vaccination of Fish - Antigen Preparations, Uptake, and Immune InductionInduction of intestinal immunity by mucosal vaccines as a means of controlling HIV infectionProphylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model.Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patchIntestinal M cells: the fallible sentinels?Lower levels of gamma interferon expressed by a pseudotyped single-cycle simian immunodeficiency virus enhance immunogenicity in rats.Vaccine design for CD8 T lymphocyte responsesProtection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity.Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice.Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.Dynamic T cell migration program provides resident memory within intestinal epitheliumCholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins.Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections.A rational basis for mucosal vaccination against HIV infection.Mucosal immunity and tolerance: relevance to vaccine development.Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the "Antigen Capsid-Incorporation" strategy.Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway.Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunityMucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumorsSystemic immunity and mucosal immunity are induced against human immunodeficiency virus Gag protein in mice by a new hyperattenuated strain of Listeria monocytogenesGranulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells.Memories that last forever: strategies for optimizing vaccine T-cell memory.The influence of delivery vectors on HIV vaccine efficacyA Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice.Clearance of HIV type 1 envelope recombinant sendai virus depends on CD4+ T cells and interferon-gamma but not B cells, CD8+ T cells, or perforin.Immunomodulation using bacterial enterotoxins.Cervicovaginal lamina propria lymphocytes: phenotypic characterization and their importance in cytotoxic T-lymphocyte responses to simian immunodeficiency virus SIVmac251Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques.Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques.Elicitation of simian immunodeficiency virus-specific cytotoxic T lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccination.How can we design better vaccines to prevent HIV infection in women?Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system.Mucosal and systemic anti-HIV immunity controlled by A20 in mouse dendritic cellsIntrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice.Strategies for designing and optimizing new generation vaccines.Gp96 SIV Ig immunization induces potent polyepitope specific, multifunctional memory responses in rectal and vaginal mucosa
P2860
Q24642027-9277F75F-0C98-447E-BAA3-90FD2DC5AD6DQ26779419-3FDE96C6-5FC1-4FDE-B8F5-AE905CAF5506Q27001897-F4B8B0BD-2C06-466D-A05A-80CA9C5E31B7Q27488288-BCCBA483-6AF8-4C5A-97A4-553C4FD63F1FQ28252883-34D084E2-6A11-4D00-8FD8-36FAC7040C07Q30050457-5D142A3D-CF02-4A00-BE09-51A65EC6719AQ30373857-8771A715-4F72-433D-9D87-3F6EB65DBD5BQ30411492-483308DB-DF43-46D9-92E0-7CA201976E54Q30449492-E9D3F837-9388-40FF-8C97-DA40AC1CDD10Q30490467-FE27AF91-6AB1-4C98-B053-585600BB4E29Q33609436-236434F7-DE00-46D4-AC98-C3876E8AB5F7Q33611645-E880CFA2-C7BE-4CA5-B04C-46F2196536F9Q33730150-624E7643-AF53-422E-B38E-FB45AA4F5A48Q33768109-8CC54282-24DF-4C2B-ABEA-E94B9C89F0B9Q33776155-07A9D0F2-69E1-4618-9613-7DEEEEF2E291Q33776167-D2077816-2B66-4A0E-9382-FA207FA10126Q33776172-E01050CC-4B82-44AC-BB03-139B77629F1AQ33784928-46D1A95C-BAB7-40BF-A76D-DE31228D8769Q33786140-801BFFB9-FE93-4581-AC1C-0E0B967D7D38Q33806715-B7813450-D279-4960-AAAE-3CDEA563ED80Q33809753-FB55AC28-570C-4A8F-A153-8665CD9A5A81Q33846454-1BB96302-6DC2-48AA-9540-8675AF8DB922Q33862822-18D3D10E-F8D3-450B-82CD-F224133EFDADQ33865731-784B0FF2-FE62-4165-B411-C91363751620Q33870105-7DA57C4B-FC01-4B58-BBB3-998FBD7D3469Q34060493-8BEF3157-FD9B-46DB-8146-029305745C8FQ34077543-7CE60DBA-14D7-4099-A080-AC2C75DFAB57Q34098868-3F524341-8FA7-416B-8105-DDCE559DAA6CQ34100215-F3FD42BB-B8EB-448F-BA6E-67B4F808693EQ34184898-C25A422D-71C2-4ED8-A361-4CD2034886CBQ34326721-7EA460F2-1E52-4974-8896-B5FA81A653F9Q34331629-1AB8A109-7D81-44DC-97F3-FB2A02A79447Q34355037-AF2BF426-7009-4D8C-B85F-75BA662F7223Q34355284-AE8B8FC2-D8DE-4E67-AD55-E5D5F4245EC6Q34449068-06677C25-F895-4526-9CB8-88109E9FAC8DQ34471356-D5F95A9C-F14D-44E0-9D62-BE1AF98B3357Q34519838-62A3806F-78B6-47E3-802F-19D95F0870F2Q34545847-6FFB7160-5517-487B-9D2C-7E9F88CA89C7Q34572198-A47DC222-6442-44CA-A10A-AB9266A9375CQ34727695-92A77A2B-4C5A-4505-94AF-634B532258C6
P2860
Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Mucosal immunization with HIV- ...... binant HIV-vaccinia challenge.
@ast
Mucosal immunization with HIV- ...... binant HIV-vaccinia challenge.
@en
type
label
Mucosal immunization with HIV- ...... binant HIV-vaccinia challenge.
@ast
Mucosal immunization with HIV- ...... binant HIV-vaccinia challenge.
@en
prefLabel
Mucosal immunization with HIV- ...... binant HIV-vaccinia challenge.
@ast
Mucosal immunization with HIV- ...... binant HIV-vaccinia challenge.
@en
P2093
P2860
P921
P356
P1476
Mucosal immunization with HIV- ...... binant HIV-vaccinia challenge.
@en
P2093
B L Kelsall
I M Belyakov
J A Berzofsky
J D Ahlers
P2860
P304
P356
10.1073/PNAS.95.4.1709
P407
P577
1998-02-01T00:00:00Z